申请人:Cho Aesop
公开号:US20070027116A1
公开(公告)日:2007-02-01
Phosphorus substituted mycophenolate derivatives with anti-cancer, anti-viral, anti-inflammatory and anti-tissue/organ transplant rejection properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit tumor growth, viral growth, inflammation, and tissue/organ transplant rejection and/or are useful therapeutically for the treatment or prevention of cancer, viral infection, inflammation and tissue/organ transplant rejection, as well as in assays for the detection of cancer, viral infection, inflammation and tissue/organ transplant rejection.
公开了含有抗癌、抗病毒、抗炎症和抗组织/器官移植排斥作用的磷取代的麦考酚酯衍生物,具有治疗用途和其他工业用途。这些组合物抑制肿瘤生长、病毒生长、炎症和组织/器官移植排斥,或在治疗或预防癌症、病毒感染、炎症和组织/器官移植排斥方面有用,以及在癌症、病毒感染、炎症和组织/器官移植排斥检测中有用。